Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Vanda Pharmaceuticals (VNDA) Catches Eye: Stocks Up 20%
Vanda Pharmaceuticals, Inc. (VNDA - Free Report) was a big mover last session, as the company saw its shares rise over 20% on the day. The news also led to far more shares changing hands than in a normal session, resulting in solid volume. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $11.20 to $12.96 in the past one-month time frame.
The company has seen three positive estimate revisions over the past 30 days, while its Zacks Consensus Estimate moved lower suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.
Vanda Pharmaceuticals has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Another better-ranked stock in the same industry is Anika Therapeutics Inc. (ANIK - Free Report) , sporting a Zacks Rank #1 (Strong Buy).
Is VNDA going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>